Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses

PLoS Pathogens

Volumn 12, Issue 8, 2016, Pages

  Linderman, Susanne L ^a,b   Hensley, Scott E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H2 S37B; MONOCLONAL ANTIBODY H5 42B; MONOCLONAL ANTIBODY H5 61B; UNCLASSIFIED DRUG; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY; VIRUS ANTIGEN;

ABSORPTION ASSAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BIOASSAY; CONTROLLED STUDY; CROSS REACTION; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; HEMAGGLUTINATION INHIBITION TEST; IMMUNE RESPONSE; INFLUENZA VIRUS; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSIN; SOMATIC MUTATION; SPLEEN CELL; TCID50 ASSAY; VIRUS STRAIN; ANIMAL; ANTIBODY AFFINITY; BAGG ALBINO MOUSE; DISEASE MODEL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); ORTHOMYXOVIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; B-LYMPHOCYTES; CROSS REACTIONS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84984817800     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005806     Document Type: Article

References (28)

1. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell31: 417–427. 6186384
2. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE, Jr. (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature455: 532–536. doi: 10.1038/nature0723118716625
3. Bodewes R, de Mutsert G, van der Klis FR, Ventresca M, Wilks S, Smith DJ, Koopmans M, Fouchier RA, Osterhaus AD, Rimmelzwaan GF, (2011) Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol18: 469–476. doi: 10.1128/CVI.00396-1021209157
4. Kucharski AJ, Lessler J, Read JM, Zhu H, Jiang CQ, Guan Y, Cummings DA, Riley S, (2015) Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data. PLoS Biol13: e1002082. doi: 10.1371/journal.pbio.100208225734701
5. Francis T, (1960) On the Doctrine of Original Antigenic Sin. Proceedings of the American Philosophical Society104: 572.
6. de St.Groth SF, Webster RG, (1966) DISQUISITIONS ON ORIGINAL ANTIGENIC SIN. The Journal of experimental medicine124: 331–345.
7. Kim JH, Skountzou I, Compans R, Jacob J, (2009) Original antigenic sin responses to influenza viruses. J Immunol183: 3294–3301. doi: 10.4049/jimmunol.090039819648276
8. Kim JH, Davis WG, Sambhara S, Jacob J, (2012) Strategies to alleviate original antigenic sin responses to influenza viruses. Proc Natl Acad Sci U S A109: 13751–13756. doi: 10.1073/pnas.091245810922869731
9. Gerhard W, Yewdell J, Frankel ME, Webster R, (1981) Antigenic Structure of Influenza-Virus Hemagglutinin Defined by Hybridoma Antibodies. Nature290: 713–717. 6163993
10. Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW, (2013) Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection. Cell Host & Microbe13: 314–323.
11. Plotkin SA, (2010) Correlates of protection induced by vaccination. Clin Vaccine Immunol17: 1055–1065. doi: 10.1128/CVI.00131-1020463105
12. Hensley SE, (2014) Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol8C: 85–89.
13. Schultz-Cherry S, Jones JC, (2010) Influenza vaccines: the good, the bad, and the eggs. Adv Virus Res77: 63–84. doi: 10.1016/B978-0-12-385034-8.00003-X20951870
14. Stohr K, Bucher D, Colgate T, Wood J, (2012) Influenza virus surveillance, vaccine strain selection, and manufacture. Methods Mol Biol865: 147–162. doi: 10.1007/978-1-61779-621-0_922528158
15. Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE, (2015) Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza Season. Cell Rep12: 1–6. doi: 10.1016/j.celrep.2015.06.00526119736
16. Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, Reyes-Teran G, Ross TM, Wilson PC, Ahmed R, Bloom JD, Hensley SE, (2014) Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season. Proc Natl Acad Sci U S A111: 15798–15803. doi: 10.1073/pnas.140917111125331901
17. Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE, (2013) Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med210: 1493–1500. doi: 10.1084/jem.2013021223857983
18. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, Mulligan M, Das SR, Yewdell JW, Mehta AK, Wilson PC, Ahmed R, (2012) Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc Natl Acad Sci U S A109: 9047–9052. doi: 10.1073/pnas.111897910922615367
19. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, McCausland M, Skountzou I, Hornig M, Lipkin WI, Mehta A, Razavi B, Del Rio C, Zheng NY, Lee JH, Huang M, Ali Z, Kaur K, Andrews S, Amara RR, Wang Y, Das SR, O'Donnell CD, Yewdell JW, Subbarao K, Marasco WA, Mulligan MJ, Compans R, Ahmed R, Wilson PC, (2011) Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med208: 181–193. doi: 10.1084/jem.2010135221220454
20. Engels N, Konig LM, Heemann C, Lutz J, Tsubata T, Griep S, Schrader V, Wienands J, (2009) Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol10: 1018–1025. doi: 10.1038/ni.176419668218
21. Kometani K, Nakagawa R, Shinnakasu R, Kaji T, Rybouchkin A, Moriyama S, Furukawa K, Koseki H, Takemori T, Kurosaki T, (2013) Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity39: 136–147. doi: 10.1016/j.immuni.2013.06.01123850379
22. Liu W, Chen E, Zhao XW, Wan ZP, Gao YR, Davey A, Huang E, Zhang L, Crocetti J, Sandoval G, Joyce MG, Miceli C, Lukszo J, Aravind L, Swat W, Brzostowski J, Pierce SK, (2012) The scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptors. Sci Signal5: ra54. doi: 10.1126/scisignal.200282022855505
23. Davenport FM, Hennessy AV, Francis T, Jr. (1953) Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J Exp Med98: 641–656. 13109114
24. Webster RG, (1966) Original antigenic sin in ferrets: the response to sequential infections with influenza viruses. J Immunol97: 177–183. 5921310
25. Fazekas de St G, Webster RG, (1966) Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med124: 331–345. 5922742
26. Francis T, Jr. (1955) The current status of the control of influenza. Ann Intern Med43: 534–538. 13249235
27. Wang Z, Raifu M, Howard M, Smith L, Hansen D, Goldsby R, Ratner D, (2000) Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity. Journal of Immunological Methods233: 167–177. 10648866
28. Ramsden DA, Paige CJ, Wu GE, (1994) Kappa light chain rearrangement in mouse fetal liver. The Journal of Immunology153: 1150–1160. 8027546